Accuray Inc (ARAY)
2.08
+0.06
(+2.98%)
USD |
NASDAQ |
Nov 07, 16:00
2.10
+0.02
(+0.96%)
After-Hours: 20:00
Accuray Revenue (Annual): 446.55M for June 30, 2024
Revenue (Annual) Chart
Historical Revenue (Annual) Data
Date | Value |
---|---|
June 30, 2024 | 446.55M |
June 30, 2023 | 447.60M |
June 30, 2022 | 429.91M |
June 30, 2021 | 396.29M |
June 30, 2020 | 382.93M |
June 30, 2019 | 418.78M |
June 30, 2018 | 404.90M |
June 30, 2017 | 383.41M |
June 30, 2016 | 398.80M |
June 30, 2015 | 379.80M |
June 30, 2014 | 369.42M |
June 30, 2013 | 315.97M |
Date | Value |
---|---|
June 30, 2012 | 409.22M |
June 30, 2011 | 222.28M |
June 30, 2010 | 221.62M |
June 30, 2009 | 233.60M |
June 30, 2008 | 210.38M |
June 30, 2007 | 140.45M |
June 30, 2006 | 52.90M |
June 30, 2005 | 22.38M |
June 30, 2004 | 19.57M |
June 30, 2003 | 2.71M |
June 30, 2002 | 19.35M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
382.93M
Minimum
2020
447.60M
Maximum
2023
420.66M
Average
429.91M
Median
2022
Revenue (Annual) Benchmarks
Boston Scientific Corp | 14.24B |
Baxter International Inc | 14.81B |
AngioDynamics Inc | 303.91M |
Masimo Corp | 2.048B |
Perspective Therapeutics Inc | -- |